Bain, S., Bain, S. C., Mosenzon, O., Arechavaleta, R., Bogdański, P., Comlekci, A., . . . Husain, M. (2018). Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial. Diabetes, Obesity and Metabolism. doi:10.1111/dom.13553
Chicago Style CitationBain, Steve, et al. "Cardiovascular Safety of Oral Semaglutide in Patients With Type 2 Diabetes: Rationale, Design and Patient Baseline Characteristics for the PIONEER 6 Trial." Diabetes, Obesity and Metabolism 2018.
MLA CitationBain, Steve, et al. "Cardiovascular Safety of Oral Semaglutide in Patients With Type 2 Diabetes: Rationale, Design and Patient Baseline Characteristics for the PIONEER 6 Trial." Diabetes, Obesity and Metabolism 2018.